Loading…

Isolation of Acetylcholinesterase Inhibitors from the Flowers of Chrysanthemum indicum Linne

There have been interests in finding new sources of acetylcholinesterase (AChE) inhibitors to treat Alzheimer’s disease, because only few AChE inhibitors such as galanthamine, physostigmine, and tacrine are currently available in clinical use. In the present study we observed that the ethanol extrac...

Full description

Saved in:
Bibliographic Details
Published in:The FASEB journal 2007, Vol.21 (6), p.LB39-LB40
Main Authors: Jeung, Seung‐Kyoung, Yim, Hyun Jae, Kim, Hye Mi, Shin, Se Gye, Han, Seoung Jun, Park, Jung HY, Kang, Il‐Jun
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:There have been interests in finding new sources of acetylcholinesterase (AChE) inhibitors to treat Alzheimer’s disease, because only few AChE inhibitors such as galanthamine, physostigmine, and tacrine are currently available in clinical use. In the present study we observed that the ethanol extract of the flowers of Chrysanthemum indicum Linne markedly decreased AChE activity. Using a bio‐guided fractionation strategy we identified acaciin and acacetin‐7‐O‐β‐D‐galactopyranoside as active compounds responsible for the AChE inhibition. In addition, we investigated the relationship between structure and activity with five flavonoids (acaciin, acacetin‐7‐O‐β‐D‐galactopyranoside, luteolin, and two other commercially available flavonoids, i. e. apigenin and acacetin) and observed that the presence of methoxy groups at C‐4′ and a sugar at O‐7 in ring A was essential for the inhibition of AChE. The present results suggest that acaciin and acacetin‐7‐O‐β‐D‐galactopyranoside from the flowers of Chrysanthemum indicum Linne have potential as therapeutic agents for Alzheimer’s disease.
ISSN:0892-6638
1530-6860
DOI:10.1096/fasebj.21.6.LB39-d